Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dissecting Aneurysm of the Thoracic Aorta”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00351039
What this trial is testing

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableStudy completedNCT03838757
What this trial is testing

Maximal Exercise Capacity and Extra-pulmonary Characteristics in Patients With Lung Cancer With Complete Remission .

Who this might be right for
Lung Cancer
Gazi University 40
Testing effectiveness (Phase 2)Study completedNCT00918281
What this trial is testing

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

Who this might be right for
Solid TumorsHigh Grade GliomasLung Cancer+4 more
GE Healthcare 70
Early research (Phase 1)Study completedNCT01225302
What this trial is testing

Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05690945
What this trial is testing

QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Qilu Pharmaceutical Co., Ltd. 606
Early research (Phase 1)Looking for participantsNCT04952272
What this trial is testing

Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors

Who this might be right for
Lung CancerHepatocellular CarcinomaSolid Tumor
Second Affiliated Hospital of Guangzhou Medical University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07707895
What this trial is testing

DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers

Who this might be right for
Small Cell Lung CancerLarge Cell Neuroendocrine Lung CarcinomaExtrapulmonary Neuroendocrine Carcinoma of Small Cell Histology+1 more
Boehringer Ingelheim 60
Not applicableLooking for participantsNCT04545502
What this trial is testing

PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches

Who this might be right for
AneurysmDissectionAortic Root Aneurysm+6 more
Vascutek Ltd. 2,000
Not applicableNot Yet RecruitingNCT07084753
What this trial is testing

Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy

Who this might be right for
Obese PatientsBariatric Surgical PainBariatric Surgery (Sleeve Gastrectomy )+6 more
IVO JURISIC 36
Early research (Phase 1)UnknownNCT01242072
What this trial is testing

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Who this might be right for
MalignancyCancerNon Small Cell Lung Cancer+5 more
Alaunos Therapeutics 12
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Early research (Phase 1)Study completedNCT00967577
What this trial is testing

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

Who this might be right for
Kidney CancerHead and Neck CancerBreast Cancer+6 more
Weill Medical College of Cornell University 20
Not applicableActive Not RecruitingNCT05537701
What this trial is testing

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)

Who this might be right for
Non-small Cell Lung Cancer
Centre Hospitalier Universitaire de Liege 316
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07004712
What this trial is testing

Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 46
Testing effectiveness (Phase 2)Study completedNCT01213030
What this trial is testing

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Who this might be right for
Head and Neck CancerLung CancerLiver Cancer
Siemens Molecular Imaging 12
Not applicableStudy completedNCT05046067
What this trial is testing

Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery

Who this might be right for
Lung Neoplasm
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)UnknownNCT01707329
What this trial is testing

Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment

Who this might be right for
Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT00831545
What this trial is testing

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Who this might be right for
Metastases of Central Nervous SystemMelanomaBreast Neoplasm+1 more
Merck Sharp & Dohme LLC 162
Not applicableStudy completedNCT05791045
What this trial is testing

Single Lumen Intubation and Heart-Lung Machine (HLM) Mode Ventilation

Who this might be right for
Anesthesia Time
Biruni University 135
Early research (Phase 1)Ended earlyNCT06560645
What this trial is testing

PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Carcinoma+7 more
Prelude Therapeutics Incorporated 42
Next Page